Nakagawa, Ryoya
Hirano, Hisato
Omura, Satoshi N.
Nety, Suchita http://orcid.org/0000-0002-4201-1061
Kannan, Soumya http://orcid.org/0000-0002-7332-9662
Altae-Tran, Han
Yao, Xiao
Sakaguchi, Yuriko
Ohira, Takayuki http://orcid.org/0000-0002-1487-1312
Wu, Wen Y.
Nakayama, Hiroshi
Shuto, Yutaro
Tanaka, Tatsuki
Sano, Fumiya K.
Kusakizako, Tsukasa http://orcid.org/0000-0002-6186-6647
Kise, Yoshiaki
Itoh, Yuzuru
Dohmae, Naoshi http://orcid.org/0000-0002-5242-9410
van der Oost, John http://orcid.org/0000-0001-5024-1871
Suzuki, Tsutomu
Zhang, Feng http://orcid.org/0000-0003-0178-7995
Nureki, Osamu http://orcid.org/0000-0003-1813-7008
Article History
Received: 4 October 2022
Accepted: 8 March 2023
First Online: 5 April 2023
Competing interests
: F.Z. is a co-founder of Editas Medicine, Beam Therapeutics, Pairwise Plants, Arbor Biotechnologies and Sherlock Biosciences. J.v.d.O. is a co-founder of NTrans Technologies and a scientific advisor for NTrans Technologies, Scope Biosciences and Hudson River Biotechnology. O.N. is a co-founder, board member and scientific advisor for Curreio. The remaining authors declare no competing interests.